COVID-19: ‘Army’ of volunteers join NHS as BMS postpones new study starts

26th March 2020 Uncategorised 0

The FDA has also granted Gilead’s wishes to withdraw orphan drug designation for remdesivir under current circumstances.

More: COVID-19: ‘Army’ of volunteers join NHS as BMS postpones new study starts
Source: News